“…In this study, not only the disease progression was more rapid in homozygous patients, but also homozygous patients appeared to have a wider spectrum of neurological symptoms. More recent work involving cell lines derived from heterozygous and homozygous HD patients (Mormone et al , 2006; Squitieri et al , 2010; Varani et al , 2003) and analyses of mouse models for HD (Fossale et al , 2002; Graham et al , 2006; Lin et al , 2001) also support the notion that HD is more severe in homozygosity. Thus, more recent work is consistent with the notion that, like other triplet repeat disorders, HD is not a true dominant disorder, and that gain of function is only one of the facets of this devastating disease.…”